Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05985148

A Study of Stereotactic Radiosurgery (SRS) to Treat Pain in the Chest and/or Stomach Wall

A Phase I Dose Escalation Trial for Treatment of Chronic Thoracoabdominal Wall Pain Through Ablation of the Dorsal Spinal Nerve Using Single-Fraction Stereotactic Radiosurgery

Status
Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
18 (estimated)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The researchers are doing this study to find out whether stereotactic radiosurgery (SRS) is a safe, practical (feasible), and effective treatment for people with chronic TAWP. The researchers will test different doses of SRS to find the highest dose that causes few or mild side effects.

Conditions

Interventions

TypeNameDescription
RADIATIONSingle-fraction stereotactic radiosurgery (SRS)Patients will be treated with single-fraction radiation therapy at three dose levels: 70 Gy, 80 Gy, and 90 Gy using image-guided SRS techniques.

Timeline

Start date
2023-08-02
Primary completion
2028-08-01
Completion
2028-08-01
First posted
2023-08-14
Last updated
2026-01-20

Locations

7 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05985148. Inclusion in this directory is not an endorsement.